Individuals with CF who have compound heterozygous CF-causing mutations with ΔI1023_V1024-CFTR exhibit classic CF symptoms, such as pancreatic insufficiency, a reduction in percentage predicted forced expiratory volume in 1 s (ppFEV1), and increased sweat chloride concentrations [7]. The gene discussed is CFTR; the disease is cystic fibrosis.